Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grow Group is a leading European biopharmaceutical company focused on the research, development, and distribution of medical cannabis-based medicines. The company operates through two primary divisions: Grow Biotech, which focuses on intellectual property and proprietary extraction technologies, and Grow Pharma, which handles the distribution and clinical support for cannabis-based products. By bridging the gap between producers and healthcare professionals, Grow Group aims to standardize medical cannabis treatments and improve patient access across the UK and Europe. Their business model integrates R&D with a robust supply chain to provide high-quality, pharmaceutical-grade cannabinoid therapies for indications such as chronic pain and neurological disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GROW.